Chlamydia Eyed for Hit List

Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.

Chlamydia Eyed for Hit List

New Zealand Herald (12.26.02) - Tuesday, December 31, 2002
Bridget Carter

As part of a major review of New Zealand's Health Act, health officials hope to reclassify chlamydia, one of the country's most common STDs, as a notifiable infection. If they succeed, people diagnosed with chlamydia would, by law, have to identify recent partners who would be contacted, and doctors would have to report every case of the disease to the medical officer of health. Health clinics currently trace chlamydia contacts only with the patient's informed consent.

Dr. Doug Lush, the Ministry of Health's senior adviser on communicable diseases, said chlamydia cases are rising. Making the infection notifiable would provide detailed information to help the ministry launch appropriate education and control programs.

The Institute of Environmental Science and Research reported that New Zealand's chlamydia rates are five times higher than the rates in Britain, Canada and Australia. Cases jumped from 2,870 in 2000 to 3,238 in 2001.

Northland has launched a pilot program involving general practitioners to determine the costs of such an effort. Dr. Jonathan Jarman, Northland's medical officer of health, said, "The disease is running away on us." He noted that making it notifiable would allow nurses to get in early and "hit it hard."

But Dr. Phil Shoemack, the Bay of Plenty's medical officer of health, expressed reservations about making chlamydia notifiable. He said people might avoid treatment, especially if they were having a relationship "on the side."

Dr. Tricia Briscoe, chair of the general practitioners council of the Medical Association, said she supports the reclassification only if more funding accompanies it, because it would mean more work for GPs.
021231
AD022519

Copyright © 2002 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.